TerraBioGen Technologies Inc.
TSX VENTURE : TBG

TerraBioGen Technologies Inc.

December 05, 2011 11:57 ET

TerraBioGen Announces Results of 2011 Crop Trials

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 5, 2011) -

NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TerraBioGen Technologies Inc. (TSX VENTURE:TBG), a developer and marketer of proprietary technologies for the production of organic-based, high-value agricultural products from organic wastes, announces the results of crop trials during the 2011 growing season.

The Company conducted growing trials through the summer of 2011 in Ontario on field tomatoes and potatoes. The tomato trials, which were carried out in a grower's field in collaboration with the Ridgetown Campus of the University of Guelph under the management of A&L Biologicals of London, Ontario, consisted of at least four replications comparing TerraBioGen product against the grower's standard treatment and several competitive products. In trials with both potatoes and tomatoes the TerraBioGen products outperformed the controls and competitive products and showed up to 35% yield increase in tomatoes and a 29% yield increase in potatoes over the grower's standard. The use of the TerraBioGen product showed evidence of reduced levels of some pathogens known to cause root lesions associated with tomato vine decline. Increased growth responses and healthier plants were clearly demonstrated in growth room studies carried out with wheat, cucumber and radishes.

Blair Heffelfinger, President and CEO of TerraBioGen, said: "It is a pleasure to work with two of Canada's leading agricultural research organizations - the University of Guelph and A&L Biologicals. These results confirm what we have seen in the past with our products. This is the first phase of a two year project and we anticipate further advances in performance as we continue to improve our products."

Dr. George Lazarovits, the Chief Technical Officer of A&L Biologicals, said: "We are pleased with the on-going collaboration with TerraBioGen and have seen a general increase in crop health and yields, and reduced disease incidence with the use of their product. We look forward to continue working with TerraBioGen to further understand and improve the performance of their products to the benefit of the agricultural community."

About TerraBioGen Technologies

Located in North Vancouver, BC, TerraBioGen Technologies Inc. is committed to research and development to continue to improve the efficiency of its technology and the quality of its agricultural products. It is further committed to developing a world-wide marketing capability to ensure market acceptance of its products.

About A&L Biologicals

A&L Biologicals is located in London Ontario in a state-of-the-art laboratory focused on technologies that are based on ecological principles to help growers increase crop yields, reduce fertilizer costs, increase plant growth and nutrient uptake, control soilborne pests and disease, and promote practices that benefit the environment.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information